Impact Biomedical reported cash from operations of $0.47M and free cash flow of $0.47M for the quarter ended Jun 2026, up 167.7% year over year. This cash flow statement covers 17 quarters of results from Jun 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||
| Net Income | -0.80M | -2.24M | -3.37M | -0.85M | -1.12M | -1.18M | -1.26M | -1.00M | -0.88M | 4.24M | -27.10M | -1.28M | -14.35M | -1.48M | -2.28M | -0.70M | |
| Share-based CompensationStock Comp. | 0.02M | 0.03M | 0.00M | 1.44M | |||||||||||||
| Deferred Taxes | -1.88M | ||||||||||||||||
| Cash from OperationsCash from Ops. | -0.80M | -0.36M | -1.01M | -0.73M | -0.67M | -0.43M | -0.48M | -0.39M | -1.00M | -0.99M | -0.68M | -0.69M | -0.61M | 0.10M | -0.46M | 0.47M | |
| Depreciation, Depletion & Amortization | |||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.28M | 0.29M | 0.29M | 0.29M | 0.28M | 0.28M | |
| Change in Working Capital | |||||||||||||||||
| Change in ReceivablesChange Receivables | 0.01M | -0.01M | -0.01M | ||||||||||||||
| Change in InventoryChange Inventory | -0.00M | -0.00M | |||||||||||||||
| Change in Account PayablesChange Payables | -0.07M | 0.49M | -0.35M | 0.12M | 0.17M | 0.36M | 0.19M | -0.04M | 0.01M | -0.60M | -0.10M | -0.06M | 0.02M | 0.61M | 0.03M | 0.09M | |
| Change in Accured ExpensesChange Accured Exp. | 0.01M | 0.05M | -0.01M | -0.05M | 0.01M | 0.22M | -0.18M | 0.01M | 0.04M | 0.09M | 0.01M | 0.06M | 0.07M | -0.14M | 0.02M | 0.04M | |
| Investing Activities | |||||||||||||||||
| Capital ExpendituresCapex | 0.01M | 0.01M | 0.00M | ||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.00M | -0.28M | -0.00M | -0.01M | -0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | -0.00M | 0.00M | |||||
| Financing Activities | |||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.77M | 0.54M | 1.02M | 0.75M | 0.87M | 0.23M | 0.48M | 0.38M | 3.67M | 0.32M | 0.48M | ||||||
| Change in Capital Stock | |||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 18.76M | 18.04M | 18.04M | ||||||||||||||
| Additional items | |||||||||||||||||
| Change in Cash | -0.03M | -0.10M | -0.00M | 0.00M | 0.20M | -0.20M | 0.00M | 2.67M | -0.67M | -0.68M | -0.69M | -0.61M | -0.01M | 0.02M | -0.01M | ||
| Free Cash FlowFCF | -0.80M | -0.36M | -1.02M | -0.74M | -0.67M | -0.43M | -0.48M | -0.39M | -1.00M | -0.99M | -0.68M | -0.69M | -0.61M | 0.10M | -0.46M | 0.47M | |
| Net Cash FlowNCF | -0.03M | -0.10M | -0.00M | 0.00M | 0.20M | -0.20M | 0.00M | -0.00M | 2.67M | -0.67M | -0.68M | -0.69M | -0.61M | 0.10M | 0.02M | 0.47M |